A comparison of adjuvant therapy modality and treatment outcomes between appalachian and non-appalachian patients with high-risk endometrial carcinoma
Despite lower densities of subspecialists in rural Appalachia, Appalachian and non-Appalachian patients with high-risk endometrial cancer received similar adjuvant therapy regimens and had similar disease outcomes. Further efforts should work to optimize treatment and surveillance for patients with endometrial carcinoma with barriers to subspecialty care.
Authors
- Sara Lee (ORCID: https://orcid.org/0000-0001-9876-708X)
- Madison Lane
- Megan L. Hutchcraft (ORCID: https://orcid.org/0000-0002-8611-6324)
- Lauren Baldwin (ORCID: https://orcid.org/0000-0001-5180-9537)
- Gregory S. Hawk (ORCID: https://orcid.org/0000-0001-8935-9965)
- Laura M. Harbin (ORCID: https://orcid.org/0000-0003-0739-7568)
- Josie Llanora
- Madison T Hickey
- Elizabeth Pendygraft
Institutions
- Carle Foundation Hospital (US)
- University of Kentucky (US)
- University of Michigan (US)
- West Cancer Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1016/j.gore.2025.101725
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00